UTIPRO® PLUS AF reaches Central Asia

We are happy to inform that Utipro® Plus AF is ready to land in Central Asia thanks to its very recent registration in Kazakhstan.

All evidence supporting the product has been evaluated by the Kazakh Ministry of Health who validated the CE certification of the product and accepted its medical device status, thus allowing its introduction in the local market as such.

Utipro® Plus AF will be soon ready to be presented to the Kazakh scientific community, therefore reinforcing its presence worldwide.

Utipro® Plus AF complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0476, Noventure SL)